Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

4.0%

2 terminated/withdrawn out of 50 trials

Success Rate

94.3%

+7.8% vs industry average

Late-Stage Pipeline

16%

8 trials in Phase 3/4

Results Transparency

0%

0 of 33 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
19(43.2%)
Phase 1
16(36.4%)
Phase 3
6(13.6%)
Phase 4
2(4.5%)
Phase 2
1(2.3%)
44Total
N/A(19)
Phase 1(16)
Phase 3(6)
Phase 4(2)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (50)

Showing 20 of 50 trials
NCT06069869Phase 3Active Not Recruiting

Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial

Role: collaborator

NCT05881447Recruiting

Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa

Role: collaborator

NCT05426395Phase 1Active Not Recruiting

Vitamin B12 Dose Escalation Trial in Pregnancy

Role: collaborator

NCT06069856Phase 3Not Yet Recruiting

Multiple Micronutrient Supplementation (MMS) vs IFA Acceptability Crossover Trial

Role: collaborator

NCT05567016Not ApplicableCompleted

CHILD (Child Health and Infection With Low Density) Malaria

Role: collaborator

NCT07124156Phase 1Not Yet Recruiting

A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate

Role: collaborator

NCT04270838Phase 1Active Not Recruiting

A Phase Ib/II Study of the Safety and Immunogenicity of the Candidate Rabies Vaccine ChAdOx2 RabG

Role: collaborator

NCT06606860Phase 1Completed

Safety, Tolerability and PK of Single and Multiple Doses of Oxantel Pamoate Tablets

Role: collaborator

NCT06079918Phase 3Recruiting

Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania

Role: collaborator

NCT04568954Not ApplicableCompleted

TB-CAPT CORE Truenat Trial

Role: collaborator

NCT04568967Not ApplicableCompleted

TB-CAPT EXULTANT - HIV

Role: collaborator

NCT04271306Phase 1Terminated

Safety, Immunogenicity and ex Vivo Efficacy of Pfs25-IMX313/Matrix-M in Healthy Volunteers in Bagamoyo, Tanzania.

Role: collaborator

NCT05144763Not ApplicableCompleted

Dynamic CDSA to Manage Sick Children in Tanzania

Role: collaborator

NCT03350516Phase 3Completed

Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy

Role: collaborator

NCT04318002Phase 1Completed

Safety and Immunogenicity of RH5.1/Matrix-M in Adults and Infants Living in Tanzania

Role: collaborator

NCT04233242Not ApplicableCompleted

Genotype-Informed Versus Empiric Management of VirEmia

Role: collaborator

NCT05644067Phase 1Completed

Assessment of the Malaria Vaccine Candidate SumayaVac-1 in Healthy Adults Aged 18-45 Years Living in a Malaria Endemic Country

Role: collaborator

NCT05901155Not ApplicableCompleted

Impact of a Real-time Mentoring Tool on Antibiotic Prescription (medAL-mentor)

Role: collaborator

NCT03978429Not ApplicableCompleted

An mHealth Strategy to Reduce Pre-Eclampsia and Infant Death in Tanzania

Role: collaborator

NCT06172686Phase 1Unknown

In-vivo Transmission Model in Semi-immune Adults

Role: lead